Idexx Laboratories (IDXX) Tax Provisions (2009 - 2026)

Idexx Laboratories has reported Tax Provisions for 18 years, with the latest figure at $78.8 million in Q2 2026.

• On a quarterly basis, Tax Provisions rose 15.28% year-over-year to $78.8 million in Q2 2026; TTM through Jun 2026 was $284.8 million, a 17.63% increase from a year earlier, with the FY2025 full-year figure at $264.7 million, up 19.26% from the prior year.
• Tax Provisions was $78.8 million for Q2 2026 at Idexx Laboratories, up from $77.0 million in the prior quarter.
• The five-year high for Tax Provisions was $78.8 million in Q2 2026, with the low at $39.1 million in Q2 2022.
• Average Tax Provisions over 5 years is $57.8 million, with a median of $57.3 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2023: Tax Provisions fell 20.4% in 2022, then jumped 57.77% in 2023.
• Over 5 years, Tax Provisions stood at $41.0 million in 2022, then increased by 10.09% to $45.1 million in 2023, then slipped by 10.87% to $40.2 million in 2024, then jumped by 46.12% to $58.8 million in 2025, then jumped by 34.05% to $78.8 million in 2026.
• The last three Tax Provisions figures came in at $78.8 million (Q2 2026), $77.0 million (Q1 2026), and $58.8 million (Q4 2025), per Business Quant data.